• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE D; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE D; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL) Back to Search Results
Catalog Number 8065977763
Device Problems Improper or Incorrect Procedure or Method (2017); Contamination /Decontamination Problem (2895)
Patient Problem Insufficient Information (4580)
Event Date 10/15/2020
Event Type  malfunction  
Manufacturer Narrative
Evaluation summary: the product was not returned for analysis.Product history and batch records were reviewed and documentation indicated the product met release criteria.The product investigation could not identify a root cause.There have been no other complaints reported in the lot number.The manufacturer internal reference number is: (b)(4).
 
Event Description
A surgeon reported that during a cataract procedure with intraocular lens implantation, foreign material was adhered to the back side of the iol.This was noticed after implantation.The foreign material was removed and the procedure was completed.The iol remains implanted.Patient harm was not reported.Additionally, it was reported that a non-qualified injector was used in combination with the iol, cartridge and viscoelastic.
 
Manufacturer Narrative
Evaluation summary: the complaint cartridge was not returned.Five cartridges were returned for the complaint lot.One of the five returned samples was opened for evaluation.The cartridge was microscopically examined with no damage observed.No particulate was observed inside the cartridge.The cartridge was functionally tested per the directions for use (dfu).No lens or cartridge damage was observed after the lens delivery.No foreign material was observed.The cartridge was cleaned for further evaluation.Top coat due stain testing was conducted with acceptable results.Product history records were reviewed and documentation indicated the product met release criteria.Qualified associated products were indicated.The root cause for the reported complaint could not be determined.No determination can be made without physical evaluation of the complaint sample.The manufacturer internal reference number is: (b)(4).
 
Event Description
The surgeon provided updated information after the initial report that the foreign material had disappeared from the iol.Patient outcome is good and there is no problem.
 
Manufacturer Narrative
The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE D
Type of Device
FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
MDR Report Key10861616
MDR Text Key218180676
Report Number1119421-2020-01733
Device Sequence Number1
Product Code MSS
Combination Product (y/n)N
PMA/PMN Number
K063155
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Remedial Action Other
Type of Report Initial,Followup,Followup
Report Date 02/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number8065977763
Device Lot Number32761895
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/24/2020
Initial Date Manufacturer Received 10/27/2020
Initial Date FDA Received11/18/2020
Supplement Dates Manufacturer Received01/10/2021
02/04/2021
Supplement Dates FDA Received02/03/2021
02/25/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
AE-9036SP.; PROVISC 0.85 OPHTH VISC.; SN(B)(6), ACRYSOF SP NATURAL.; VISCOAT 0.5ML VISCOELASTIC.
-
-